<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR35">
 <label>35.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Altice</surname>
    <given-names>FL</given-names>
   </name>
   <name>
    <surname>Bruce</surname>
    <given-names>RD</given-names>
   </name>
   <name>
    <surname>Lucas</surname>
    <given-names>GM</given-names>
   </name>
   <name>
    <surname>Lum</surname>
    <given-names>PJ</given-names>
   </name>
   <name>
    <surname>Korthuis</surname>
    <given-names>PT</given-names>
   </name>
   <name>
    <surname>Flanigan</surname>
    <given-names>TP</given-names>
   </name>
   <name>
    <surname>Cunningham</surname>
    <given-names>CO</given-names>
   </name>
   <name>
    <surname>Sullivan</surname>
    <given-names>LE</given-names>
   </name>
   <name>
    <surname>Vergara-Rodriguez</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Fiellin</surname>
    <given-names>DA</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study</article-title>
  <source>J Acquir Immune Defic Syndr</source>
  <year>2011</year>
  <volume>56</volume>
  <issue>Suppl 1</issue>
  <fpage>S22</fpage>
  <lpage>S32</lpage>
  <pub-id pub-id-type="doi">10.1097/QAI.0b013e318209751e</pub-id>
  <pub-id pub-id-type="pmid">21317590</pub-id>
 </element-citation>
</ref>
